FYERS
Home
/
Stocks
/
Results
/
Alpa Laboratories Results

Alpa Laboratories Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
7%6%0%3%
-60%11%16%
7%4%-7%-34%
7%11%11%12%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
ALPA
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,899.4₹456833 Cr37.7712.0762.82₹11479 Cr
9,133₹245426 Cr83.9134.04128.41₹2568 Cr
4,841.5₹187320 Cr85.8916.7297.06₹2163 Cr
1,129.3₹113217 Cr25.099.4262.53₹5040 Cr
1,380.1₹112212 Cr33.299.7757.87₹3879 Cr
1,843.1₹101155 Cr92.526.829.25₹889 Cr
2,109₹97626 Cr17.6630.95154.36₹5333 Cr
2,330.9₹96859 Cr47.4213.7571.08₹1913 Cr
1,157.5₹96406 Cr29.925.3263.99₹4196 Cr
1,653.4₹93614 Cr25.2217.9596.84₹3505 Cr
63.42₹134 Cr30.70.473.15₹15 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018
₹24 Cr₹31 Cr₹29 Cr₹26 Cr₹19 Cr₹40 Cr₹26 Cr₹25 Cr₹21 Cr₹24 Cr₹27 Cr₹32 Cr₹21 Cr₹29 Cr₹27 Cr₹14 Cr₹22 Cr₹25 Cr₹29 Cr₹26 Cr₹32 Cr₹25 Cr₹33 Cr₹24 Cr₹16 Cr₹18 Cr₹24 Cr₹24 Cr₹20 Cr₹19 Cr₹26 Cr₹16 Cr
₹6 Cr-₹16 L₹91 L₹3 Cr₹12 Cr₹2 Cr₹9 Cr₹7 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹5 Cr-₹69 L₹3 Cr₹6 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹66 L₹1 Cr₹27 L₹2 Cr₹78 L₹1 Cr₹27 L₹71 L₹2 Cr₹59 L₹1 Cr
₹30 Cr₹31 Cr₹30 Cr₹29 Cr₹31 Cr₹42 Cr₹35 Cr₹32 Cr₹27 Cr₹28 Cr₹31 Cr₹35 Cr₹27 Cr₹28 Cr₹30 Cr₹20 Cr₹24 Cr₹27 Cr₹32 Cr₹29 Cr₹36 Cr₹26 Cr₹34 Cr₹24 Cr₹18 Cr₹19 Cr₹25 Cr₹24 Cr₹21 Cr₹21 Cr₹27 Cr₹17 Cr
₹29 Cr₹28 Cr₹28 Cr₹29 Cr₹19 Cr₹40 Cr₹26 Cr₹22 Cr₹21 Cr₹21 Cr₹26 Cr₹30 Cr₹21 Cr₹20 Cr₹25 Cr₹20 Cr₹21 Cr₹25 Cr₹26 Cr₹23 Cr₹29 Cr₹24 Cr₹31 Cr₹23 Cr₹15 Cr₹20 Cr₹23 Cr₹23 Cr₹20 Cr₹23 Cr₹24 Cr₹17 Cr
₹2 Cr₹3 Cr₹2 Cr₹82 L₹12 Cr₹3 Cr₹10 Cr₹10 Cr₹6 Cr₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹9 Cr₹5 Cr₹64 L₹3 Cr₹3 Cr₹6 Cr₹6 Cr₹7 Cr₹2 Cr₹4 Cr₹1 Cr₹4 Cr-₹40 L₹3 Cr₹1 Cr₹2 Cr-₹50 L₹3 Cr₹1 Cr
₹11 L₹15 L₹3 L₹3 L₹5 L₹2 L₹9 L₹5 L₹5 L₹29 L₹2 L₹2 L₹5 L₹4 L₹7 L₹8 L₹3 L₹5 L₹8 L₹6 L₹4 L₹80,000₹2 L₹5 L₹2 L₹3 L₹3 L₹5 L₹9 L₹7 L₹10 L₹22 L
₹98 L₹3 Cr₹2 Cr₹11 L₹12 Cr₹2 Cr₹9 Cr₹10 Cr₹5 Cr₹7 Cr₹5 Cr₹6 Cr₹6 Cr₹8 Cr₹5 Cr₹20 L₹3 Cr₹2 Cr₹5 Cr₹6 Cr₹6 Cr₹2 Cr₹4 Cr₹39 L₹3 Cr-₹1 Cr₹3 Cr₹39 L₹1 Cr-₹1 Cr₹2 Cr₹20 L
₹98 L₹1 Cr₹2 Cr₹11 L₹12 Cr-₹2 Cr₹9 Cr₹8 Cr₹5 Cr₹4 Cr₹5 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹20 L₹3 Cr-₹3 Cr₹5 Cr₹6 Cr₹6 Cr-₹2 Cr₹4 Cr₹39 L₹3 Cr-₹2 Cr₹3 Cr₹39 L₹1 Cr-₹3 Cr₹2 Cr₹20 L

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
————————————
₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr₹21 Cr
₹150 Cr₹131 Cr₹114 Cr₹101 Cr₹87 Cr₹79 Cr₹77 Cr₹77 Cr₹74 Cr₹72 Cr₹66 Cr₹67 Cr
₹150 Cr₹131 Cr₹114 Cr₹101 Cr₹87 Cr₹79 Cr₹77 Cr₹77 Cr₹74 Cr₹72 Cr₹66 Cr₹67 Cr
₹171 Cr₹152 Cr₹135 Cr₹122 Cr₹108 Cr₹100 Cr₹98 Cr₹98 Cr₹95 Cr₹93 Cr₹87 Cr₹88 Cr
₹0₹0₹78 L₹2 Cr₹91,000₹19 L₹41 L₹61 L₹47 L₹0₹0₹4 Cr
₹4 Cr₹2 Cr₹2 Cr₹3 Cr₹22 L-₹93 L-₹17 L-₹76 L-₹66 L-₹5 L-₹9 L₹1 Cr
₹0₹0₹0₹0₹0₹0₹0₹0₹63 L₹60 L₹51 L₹51 L
₹4 Cr₹2 Cr₹3 Cr₹5 Cr₹23 L-₹73 L₹24 L-₹15 L₹44 L₹55 L₹41 L₹6 Cr
————————————
₹19 Cr₹12 Cr₹15 Cr₹15 Cr₹25 Cr₹14 Cr₹13 Cr₹13 Cr₹14 Cr₹19 Cr₹9 Cr₹11 Cr
₹22 Cr₹10 Cr₹11 Cr₹9 Cr₹6 Cr₹4 Cr₹6 Cr₹4 Cr₹4 Cr₹5 Cr₹2 Cr₹5 Cr
₹3 L₹4 Cr₹0₹2 Cr₹0₹0₹1 Cr₹5 Cr₹10 Cr₹24 Cr₹29 Cr₹16 Cr
₹6 Cr₹2 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹2 Cr₹1 Cr₹2 Cr₹5 Cr₹1 Cr₹74 L
₹47 Cr₹28 Cr₹30 Cr₹29 Cr₹33 Cr₹21 Cr₹22 Cr₹23 Cr₹30 Cr₹52 Cr₹41 Cr₹32 Cr
₹223 Cr₹182 Cr₹167 Cr₹155 Cr₹140 Cr₹120 Cr₹121 Cr₹121 Cr₹125 Cr₹146 Cr₹128 Cr₹127 Cr
₹7 Cr₹4 Cr₹3 Cr₹5 Cr₹5 Cr₹6 Cr₹4 Cr₹3 Cr₹2 Cr₹3 Cr₹40 Cr₹1 Cr
₹3 L₹5 Cr₹2 Cr₹6 Cr₹19 L₹41 L₹2 Cr₹6 Cr₹11 Cr₹24 Cr₹29 Cr₹23 Cr
————————————
₹51 Cr₹40 Cr₹33 Cr₹34 Cr₹31 Cr₹40 Cr₹39 Cr₹38 Cr₹36 Cr₹35 Cr₹24 Cr₹102 Cr
₹31 Cr₹28 Cr₹26 Cr₹25 Cr₹23 Cr₹34 Cr₹31 Cr₹28 Cr₹25 Cr₹20 Cr₹19 Cr₹29 Cr
₹21 Cr₹11 Cr₹7 Cr₹9 Cr₹7 Cr₹6 Cr₹8 Cr₹10 Cr₹11 Cr₹15 Cr₹5 Cr₹73 Cr
₹0₹0₹0₹0₹2 Cr₹81 L₹12 L₹0₹0₹49,000₹7 L₹0
₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹10 Cr₹17 Cr₹19 Cr₹13 Cr₹5 Cr₹12 Cr₹10 Cr₹0
₹7 Cr₹7 Cr₹6 Cr₹6 Cr₹10 Cr₹17 Cr₹19 Cr₹13 Cr₹5 Cr₹12 Cr₹10 Cr₹0
₹72 L₹52 L₹1 Cr₹22 L₹23 L₹24 L₹13 L₹0₹0₹69 L₹62 L₹84 L
₹1 Cr₹3 Cr₹3 Cr₹2 Cr₹11 L₹20 L₹30 L₹0₹0₹0₹0₹0
₹30 Cr₹21 Cr₹18 Cr₹17 Cr₹19 Cr₹25 Cr₹27 Cr₹23 Cr₹20 Cr₹27 Cr₹16 Cr₹74 Cr
————————————
₹110 Cr₹91 Cr₹72 Cr₹69 Cr₹41 Cr₹39 Cr₹30 Cr₹18 Cr₹8 Cr₹0₹0₹0
₹18 Cr₹14 Cr₹13 Cr₹15 Cr₹17 Cr₹13 Cr₹14 Cr₹14 Cr₹13 Cr₹15 Cr₹8 Cr₹13 Cr
₹47 Cr₹41 Cr₹47 Cr₹38 Cr₹35 Cr₹25 Cr₹30 Cr₹26 Cr₹29 Cr₹34 Cr₹24 Cr₹20 Cr
₹2 Cr₹2 Cr₹9 Cr₹2 Cr₹11 Cr₹6 Cr₹90 L₹21 Cr₹37 Cr₹37 Cr₹72 Cr₹10 Cr
₹2 Cr₹63 L₹3 Cr₹5 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹2 Cr₹11 Cr₹2 Cr₹87 L
₹13 Cr₹13 Cr₹6 Cr₹9 Cr₹15 Cr₹12 Cr₹18 Cr₹18 Cr₹16 Cr₹22 Cr₹7 Cr₹8 Cr
₹192 Cr₹161 Cr₹149 Cr₹138 Cr₹121 Cr₹95 Cr₹94 Cr₹98 Cr₹105 Cr₹119 Cr₹113 Cr₹53 Cr
₹146 Cr₹133 Cr₹119 Cr₹109 Cr₹89 Cr₹75 Cr₹72 Cr₹74 Cr₹75 Cr₹66 Cr₹71 Cr₹20 Cr
₹223 Cr₹182 Cr₹167 Cr₹155 Cr₹140 Cr₹120 Cr₹121 Cr₹121 Cr₹125 Cr₹146 Cr₹128 Cr₹127 Cr
₹81₹72₹64₹58₹51₹48₹47₹46₹45₹44₹41₹42
₹81₹72₹64₹58₹51₹48₹47₹46₹45₹44₹41₹42

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
₹26 Cr₹21 Cr₹16 Cr₹20 Cr₹11 Cr₹3 Cr₹3 Cr₹5 Cr₹6 Cr₹10 Cr-₹3 Cr-₹5 Cr
-₹16 Cr-₹9 Cr-₹2 Cr-₹8 Cr₹73 L₹6 Cr₹79 L₹82 L₹61 L-₹21 L₹6 Cr₹12 Cr
₹12 Cr-₹4 Cr-₹80 L₹1 Cr-₹10 Cr₹10 Cr-₹2 Cr-₹16 Cr₹14 Cr-₹28 Cr-₹7 Cr₹1 Cr
₹22 Cr₹7 Cr₹12 Cr₹13 Cr₹1 Cr₹19 Cr₹1 Cr-₹11 Cr₹20 Cr-₹19 Cr-₹3 Cr₹8 Cr
₹18 Cr₹4 Cr₹9 Cr₹10 Cr-₹2 Cr₹18 Cr-₹1 Cr-₹13 Cr₹17 Cr-₹22 Cr-₹2 Cr₹8 Cr
-₹12 Cr-₹13 Cr₹2 Cr-₹16 Cr₹6 Cr-₹11 Cr-₹15 Cr-₹11 Cr-₹2 Cr-₹8 Cr₹37 Cr-₹2 Cr
-₹5 Cr₹3 Cr-₹4 Cr₹5 Cr₹18 L-₹1 Cr-₹5 Cr₹9 Cr-₹15 Cr-₹6 Cr₹7 Cr₹4 Cr
₹51 L-₹7 Cr₹7 Cr-₹23 L₹4 Cr₹5 Cr-₹20 Cr-₹15 Cr₹5 L-₹35 Cr₹42 Cr₹10 Cr
₹3 Cr₹10 Cr₹2 Cr₹2 Cr₹6 Cr₹90 L₹21 Cr₹37 Cr₹37 Cr₹53 Cr₹10 Cr₹53 L
₹4 Cr₹3 Cr₹9 Cr₹2 Cr₹11 Cr₹6 Cr₹90 L₹21 Cr₹37 Cr₹17 Cr₹53 Cr₹10 Cr

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)64.00
Volume (₹)6,717.00
High (₹)64.00
Upper Circuit75.96
Low (₹)62.05
Lower Circuit50.64
Prev Close63.30
52W High (₹)99.00
Price63.42
52W Low (₹)46.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)134.41 Cr
Div. Yield (%)0.00
PE Ratio30.70
Debt to Equity0.00
Price to Book1.28
Book Value81.48
EPS (TTM)2.08
Face Value10.00
ROE (%)12.06

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ALPANSE
LTP
1W Low
1W High
Market cap (₹)
1899.4-20.6 (-1.07%)
1896.80
1984.80
4,56,833Cr
9132.5-106.5 (-1.15%)
9087
9467
2,45,426Cr
4841.5-208.5 (-4.13%)
4823
5066
1,87,320Cr
1129.3-61.7 (-5.18%)
1125.10
1187
1,13,217Cr
1380.1-43.4 (-3.05%)
1376
1426.10
1,12,212Cr
1843.1-95.4 (-4.92%)
1811.70
1949
1,01,155Cr
2109-62.5 (-2.88%)
2107.20
2192
97,626Cr
2330.9-52 (-2.18%)
2327.30
2419.20
96,859Cr
1157.7-20.3 (-1.72%)
1154.40
1179.90
96,406Cr
1653.4+8.1 (0.49%)
1622.60
1717
93,614Cr
63.42-0.35 (-0.55%)
61
65
134Cr

Alpa Laboratories Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹1.81Cr; with other income of ₹5.77Cr, profit before interest and tax came to ₹1.09Cr. Interest expense was ₹11Lakh; PBT before exceptional items stood at ₹98.1Lakh. Cost mix (full year): raw materials ₹71.65Cr; employee cost ₹14.39Cr; depreciation ₹72Lakh; other expenses ₹27.89Cr. Basis: consolidated annual results.

Alpa Laboratories Ltd Quaterly Results Key Takeaways

Alpa Laboratories Ltd reported ₹23.93Cr total income from operations in Jun 2026, softer than ₹31.4Cr in Mar 2026 but higher than ₹19.11Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹1.81Cr; with other income of ₹5.77Cr, profit before interest and tax came to ₹1.09Cr. Interest expense was ₹11Lakh, taking profit before tax to ₹98.1Lakh. After tax of ₹0 cr, profit after tax stood at ₹98.1Lakh (vs ₹1.38Cr in Mar 2026 and ₹11.77Cr in Jun 2025).